DIRS.INFO The most relevant business & tech news

☆ Cramer's Lightning Round: Medtronic is a buy
▼ + stars: | 2024-04-09 | by ( Julie Coleman | ) www.cnbc.com time to read: 1 min

Stock Chart Icon Stock chart icon Medtronic's year-to-date stock performance. Medtronic : "I think that Medtronic is a buy...I like what they're doing in AI. Stock Chart Icon Stock chart icon Riley Exploration Permian's year-to-date stock performance. Stock Chart Icon Stock chart icon Wesco's year-to-date stock performance. Stock Chart Icon Stock chart icon Cleveland-Cliffs' year-to-date stock performance.

Persons: You've, Riley, it's Organizations: Riley, Cliffs Locations: Cleveland

☆ Nvidia has a parade of partners, but these two stocks are my favorite beneficiaries
▼ + stars: | 2024-03-24 | by ( Jim Cramer | ) www.cnbc.com time to read: +23 min

That's what Nvidia needed semiconductor design firm Synopsys to do to make this next generation of chips. Right now, Nvidia has had not one, but two different breakthroughs: Accelerated computing at a ridiculously fast speed and generative artificial intelligence. I think Jensen regards Dell as a crucial partner when it comes to installing Nvidia's systems anywhere. Do I think Nvidia would like to do more business with Apple? I think Nvidia would like to do more business with everyone, including alleged opponent Intel .

Persons: Abraham Lincoln, David Herbert Donald, Jensen, It's, Jensen Huang, Lincoln, Leonardo da Vinci, da Vinci, he's, Blackwell, Grace Hooper Superchip, –, Moby Dick –, that's, they've, Adam Selipsky, Jensen laughingly, Claude, Anthropic, Dell, Michael Dell, Jensen's, it's, dink, I'm, Johnson, J, Abbott, Reckitt Benckiser, we've, CrowdStrike, ServiceNow, Bill McDermott, Tesla, Elon Musk, Lora Kolodny, That's, Frank Slootman, Ansys, Synopsys, isn't, Sundar Pichai, Satya Nadella, Larry Ellison, Nvidia's Blackwell, Mark Zuckerberg, Jim, Tim Cook, Cook, Apple, Jim Cramer's, Jim Cramer, Josh Edelson Organizations: Lincoln, GTC, Nvidia, GTC –, CNBC, Amazon, Microsoft, Google, Dell Technologies, Club, Dell, Siemens, Rockwell Automation, Cadence Design Systems, Nvidia's, Johnson, Abbott Laboratories, GE Healthcare, cybersecurity, Palo Alto, Palo, Snowflake, AMD, Autodesk, Cadence, Computer, Oracle, Apple, Justice Department, Intel, Vision, Jim Cramer's Charitable, SAP Center, AFP, Getty Locations: U.S, Silicon Valley, Lincoln, Here's, Palo Alto, Pittsburgh, Switzerland, San Jose , California

☆ Medtronic CEO on earnings: Back to growth in China after challenging few years
▼ + stars: | 2024-02-20 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMedtronic CEO on earnings: Back to growth in China after challenging few yearsGeoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.

Persons: Geoff Martha, Martha Locations: China

☆ Can you hack your brain? These companies are driving innovation in the field of brain stimulation
▼ + stars: | 2023-11-21 | by ( Pia Singh | ) www.cnbc.com time to read: +12 min

These forms of deep brain stimulation require a surgical procedure during which electrodes — which generate electrical impulses to control any abnormal brain activity — are implanted into certain areas of the brain. With enough advancement in the field, doctors expect brain stimulation techniques for both severe disorders and health-and-wellness purposes will ultimately become noninvasive. Three major players There are only three companies with FDA-approved deep brain stimulation, or DBS, treatments: Medtronic , Abbott Laboratories and Boston Scientific . The spinal cord stimulation, or SCS, business is a hotbed of innovation right now, deep brain stimulation also is a key area." There is still plenty of doubt, however, about the efficacy of at-home brain stimulation devices, which offer a less direct approach to brain stimulation and don't always require FDA oversight.

Persons: —, Bernstein, Lee Hambright, Hambright, Ali Rezai, Medtronic, Abbott, Rezai, Morningstar, Debbie Wang, Wang, Elon Musk, it's Elon Musk's, Casey Halpern, it's, Halpern, Taiwan's Organizations: Drug Administration, FDA, Abbott Laboratories, Boston, Rockefeller Neuroscience, West Virginia University, American Neuromodulation Society, Boston Scientific, DBS, FactSet, Neuroscience, BCI, University of Pennsylvania, TMS Locations: neuromodulation

☆ A value fund manager who's beaten 99% of his peers in the last three years explains how he avoids bad investments — and makes the case for 3 stocks he loves heading into 2024
▼ + stars: | 2023-11-05 | by ( James Faris | ) www.businessinsider.com time to read: +7 min

The 31-year market veteran has achieved enviable results since the start of 2005 while running the BNY Mellon Dynamic Value Fund (DAGVX) alongside co-manager Brian Ferguson. How to invest — and common mistakes to avoidLike all value fund managers, Bailer refuses to overpay for stocks — regardless of how enticing their businesses look. "It's a philosophy that's based on looking for stocks with great valuations, but not stopping with great valuations," Bailer said. Companies in the BNY Mellon Dynamic Value Fund must have both quality fundamentals and improving business momentum, Bailer said. The six largest stocks in the BNY Mellon Dynamic Value Fund were in one of two sectors, as of September 30: financials and healthcare.

Persons: John Bailer, Brian Ferguson, it's, Bailer, we've, headwinds, they've, he's, Warren Buffett, Berkshire Hathaway, Buffett, Charlie Munger Organizations: Value Fund, Companies, Value, Firms, Berkshire, JPMorgan Locations: Berkshire

☆ Exclusive: Carlyle in exclusive talks for $7 bln-plus Medtronic units deal-sources
▼ + stars: | 2023-09-29 | by ( David Carnevali | ) www.reuters.com time to read: +1 min

Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. Medtronic is seeking to streamline its portfolio and focus on its higher-growth assets, such as its heart and diabetes devices. The units that Medtronic would shed would be moved to a new company majority-owned by Carlyle, the sources said. Medtronic would retain a stake in the new company of more than 35%, the sources added. Medtronic and Carlyle declined to comment.

Persons: Dado Ruvic, Medtronic, Carlyle, David Carnevali Organizations: REUTERS, Carlyle Group Inc, Medtronic, Carlyle, Thomson Locations: New York

☆ Top Wall Street analysts select these dividend stocks to enhance returns
▼ + stars: | 2023-09-10 | by ( Tipranks.Com Staff | ) www.cnbc.com time to read: +7 min

To that effect, here are five attractive dividend stocks, according to Wall Street's top experts on TipRanks, a platform that ranks analysts based on their past performance. The analyst increased his price target for Verizon stock by $1 to $40, while maintaining AT&T's price target at $17. Also, he expects the prospects for improved free cash flow to lower net debt leverage and support the dividend payments. That said, with expectations of higher cash flow generation, Crum said that "the company should have more flexibility around growing its dividend going forward." (See Hasbro Stock Chart on TipRanks)Dell TechnologiesNext up is Dell (DELL), a maker of IT hardware and infrastructure technology, which rallied after its fiscal second-quarter results far exceeded Wall Street's estimates.

Persons: Hans Vestberg, Brendan McDermid, Wall, Michael Rollins, Rollins, MDT, Rick Wise, Geoff Martha, Wise, Drew Crum, Crum, TipRanks, Amit Daryanani, Daryanani, Dell Organizations: DELL, Verizon, New York Stock Exchange, Analysts, Verizon Communications, Citi, AT, Verizon Hedge, Hasbro, Dell Technologies, Dell, TipRanks, GPU, Walmart, &' $ Locations: New York, U.S

☆ US FDA panel votes against use of Medtronic's blood pressure treatment device
▼ + stars: | 2023-08-23 | by ( ) www.reuters.com time to read: +2 min

The same panel on Tuesday voted in favor of rival ReCor's device for use in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by drugs. Separately, while all panel members voted the device was safe to use, 6 of 13 voted against its effectiveness. Japan-based Otsuka Holdings' (4578.T) unit ReCor's device was shown to provide a benefit in lowering blood pressure in clinical trials. Medtronic's device helped to lower blood pressure at the doctor's clinic but not at home, which is considered a more accurate measure of blood pressure monitoring. The company was seeking the health regulator's nod for the device indicated for patients whose hypertension, or high blood pressure, cannot be controlled with drugs.

Persons: Andrew Kelly, Jason Weidman, Sriparna Roy, Krishna Chandra Eluri Organizations: Food and Drug Administration, FDA, REUTERS, U.S . Food, Wednesday, Otsuka Holdings, Thomson Locations: White Oak , Maryland, U.S, Japan, Europe, Bengaluru

Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. Medtronic, which makes pacemakers, catheters and other tools used in heart and gastrointestinal surgeries, joins rivals, including Abbott Laboratories (ABT.N), Stryker (SYK.N) and Boston Scientific (BSX.N), on benefiting from a rise in non-urgent surgeries. CEO Geoff Martha said trends pointed to a recovery in surgical volumes as some procedures returned to stronger than pre-pandemic levels. Whereas, revenue from its medical surgical unit rose 5.5% to $2.04 billion. Medtronic also said that it was expecting to split its patient monitoring and respiratory interventions businesses in the first half of fiscal 2025.

Persons: Dado Ruvic, Stryker, Geoff Martha, It's, Martha, Edward Jones, John Boylan, Medtronic, Bhanvi Satija, Christy Santhosh, Shweta Agarwal Organizations: REUTERS, Abbott, Abbott Laboratories, Boston, Thomson Locations: Dublin, Bengaluru

☆ Medtronic raises forecast as demand for heart devices powers upbeat results
▼ + stars: | 2023-08-22 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsAug 22 (Reuters) - Medtronic (MDT.N) on Tuesday raised its annual profit forecast, after beating first-quarter estimates on higher demand for its medical devices used in heart and gastrointestinal surgeries. A recovery in non-urgent procedures and easing staffing shortages following a decline in COVID-19 cases has boosted the demand for medical devices. Sales at Medtronic's heart devices unit, its biggest revenue driver, increased 5.5% to $2.85 billion for the first quarter, above analysts' estimates of $2.78 billion. Revenue for the quarter rose 4.5% to $7.70 billion, topping analysts' average estimate of $7.57 billion. Its adjusted profit of $1.20 per share for the quarter ended July 28 beat estimates of $1.11 per share.

Persons: Dado Ruvic, Medtronic, Stryker, Bhanvi Satija, Christy Santhosh, Shweta Agarwal Organizations: REUTERS, Abbott Laboratories, Boston, Revenue, Thomson Locations: COVID, Dublin, Bengaluru

☆ Cramer's Lightning Round: Oracle is a buy
▼ + stars: | 2023-08-09 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Medtronic's year-to-date stock portfolio. Stock Chart Icon Stock chart icon Fisker's year-to-date stock portfolio. Stock Chart Icon Stock chart icon Adtran's year-to-date stock performance. Stock Chart Icon Stock chart icon Marvell's year-to-date stock performance. Stock Chart Icon Stock chart icon Oracle's year-to-date stock performance.

Persons: It's, Con, Con Edison, We've, Jeff Organizations: GE Healthcare, Enterprise, Public Service Enterprise, Marvell, Oracle

Tom Schroeder, the whistleblower accusing Medtronic of a kickback scheme, left, is interviewed by Morgan Brennan, in Kansas City, Missouri. Schroeder said rumors circulated that Medtronic sales representatives were bribing VA staff to purchase an excessive amount of the company's inventory. The veterans hospital purchased more devices than some of the largest veterans medical facilities, according to data the VA's investigation gathered. Medtronic also said that Schroeder has "admitted under oath that he has no firsthand knowledge of any problematic procedure involving Medtronic devices." Douglas Winger, one of the Medtronic sales representatives named as a defendant in Schroeder's lawsuit, won a Medtronic President's Club award in 2016 for his sales.

Persons: Tom Schroeder, Schroeder, Becton Dickinson, Medtronic, Morgan Brennan, Schroder, Boua Xiong, Robert J, texted, Rick Ament, Ament, filet mignon, …, I'm, Brendan Donelon, Donelon, CNBC Donelon, Xiong, Douglas Winger, Winger, Kim Hodgson, Hodgson, Dole, ProPublica, John Laird Organizations: Inc, CNBC, Dole Veterans Affairs Medical Center, Dole VA, Department of Veterans Affairs, United, VA's, Department of Justice, Covidien, Dole, Medtronic, Society for Vascular, Drug Administration, FDA Locations: Kansas, United States, Kansas City , Missouri, Dublin, Ireland, Medtronic's, Wichita ., Dole, Covidien, Medtronic, Dole VA

☆ These medical device makers are driving a 'paradigm' shift in cardiac care, Piper Sandler says
▼ + stars: | 2023-06-19 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for medical device companies Boston Scientific and Medtronic, according to Piper Sandler analyst Matt O'Brien. He estimates that Boston Scientific will ring up $454 million in sales by 2025 for its Farapulse catheter. Meanwhile, Boston Scientific shares hit a record high on Friday. BSX YTD mountain Boston Scientific shares have gained more than 17% so far this year. He expects that this could prompt consolidation, providing a way for any larger AF treatment providers that have fallen behind on innovation to catch up.

Persons: Piper Sandler, Matt O'Brien, O'Brien, Medtronic, Medtronic's, Abbott, Johnson Organizations: Boston Scientific, Centers for Disease Control, PFA, Boston, EU Locations: U.S

☆ Wells Fargo upgrades this medical device maker, cites improving industry trends
▼ + stars: | 2023-04-24 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Analyst Larry Biegelsen upgraded the medical device maker to overweight from equal weight in a Sunday note, saying that shares should benefit from improving medtech trends and a "maturing" product pipeline. "We rate MDT Overweight as we believe that the company will benefit as underlying medtech markets improve as staffing shortages ease in major markets," he said. Within the company's product pipeline, Biegelsen sees the biggest potential upside from the U.S. Food and Drug Administration's approval of its upgraded insulin pump known as 780G. According to Biegelsen, Medtronic's valuation also looks attractive, trading at a sharp discount to peers. "We believe once MDT moves past its FY2024 guidance in May, the stock can re-rate on the overall medtech recovery and product pipeline," he wrote.

Feb 9 (Reuters) - A unit of medical device maker Medtronic plc (MDT.N) must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement, a Santa Ana, California federal jury said Wednesday. The jury concluded after a seven-day trial that Medtronic CoreValve LLC's Evolut devices violate a Colibri patent for replacing heart valves in patients with heart disease, representatives for the companies confirmed Thursday. A spokesperson for Medtronic said the Minneapolis-headquartered company strongly disagrees with the verdict and will appeal. It alleged doctors use Medtronic's devices in a way that infringes Colibri's patent, which covers a method for controlling the deployment of self-expanding artificial heart valves. The case is Colibri Heart Valve LLC v. Medtronic CoreValve LLC, U.S. District Court for the Central District of California, No.

☆ What diabetes is revealing about the benefits and risks of personal medicine connected to the internet
▼ + stars: | 2023-01-21 | by ( Ellen Sheng | ) www.cnbc.com time to read: +4 min

Devices such as insulin pumps, which go back decades, and continuous glucose monitors, which monitor blood sugar levels 24/7, are increasingly connected to smartphones via Bluetooth. Sleep apnea, Type 2 diabetes and remote health careIt's not just diabetes where the medical device market is offering patients new benefits from remote monitoring. The number of internet-connected medical devices grew during the pandemic, as lockdowns created a big push to treat people at home. Multiple forms of medical cybersecurity riskIndustry security experts categorize cybersecurity risks of medical devices into three buckets. Many medical devices such as insulin pumps require patients to create online accounts to download data to a computer or smartphone.

Nov 22 (Reuters) - Medtronic Plc (MDT.N) on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain disruptions, sending the medical device maker's shares down nearly 6%. Medtronic cut its revenue growth expectations for fiscal 2023 to 3.5% to 4%, from 4% to 5%. The company said cost-cutting measures will likely offset lower revenue and inflationary pressures in the second half of the year. A slower-than-anticipated recovery in supply chain disruptions impacted Medtronic's medical surgical business the most, with the unit's revenue falling 10% to $2.07 billion. Reporting by Khushi Mandowara and Bhanvi Satija in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.

☆ Stocks making the biggest moves premarket: Best Buy, Dick's Sporting, Abercrombie & Fitch and others
▼ + stars: | 2022-11-22 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines before the bell:Best Buy (BBY) – Best Buy rallied 7% in the premarket after its third-quarter results beat analyst estimates. Dick's Sporting Goods (DKS) – The sporting goods retailer reported better-than-expected third-quarter profit and revenue and an unexpected increase in comparable store sales. Dick's initially surged more than 7% in premarket trading before it dipped negative. Abercrombie & Fitch (ANF) – Abercrombie & Fitch soared 12.8% in premarket action after reporting an unexpected quarterly profit and beating Street revenue forecasts. Dell Technologies (DELL) – Dell fell 1.6% in premarket trading amid a weaker-than-expected current quarter revenue forecast.

☆ FDA warns of cybersecurity risk with certain Medtronic insulin pumps
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +2 min

Register now for FREE unlimited access to Reuters.com RegisterSignage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components including an insulin pump and a blood glucose meter that communicate wirelessly. Register now for FREE unlimited access to Reuters.com RegisterThe insulin pumps are sold through Medtronic's diabetes segment, which brought in $2.41 billion in sales in 2021 and accounted for 8% of the company's total revenue. The FDA said it was working with Medtronic to identify, communicate and prevent adverse events related to this risk. Register now for FREE unlimited access to Reuters.com RegisterReporting by Mrinalika Roy in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.

Search resuls for: "Medtronic's"

19 mentions found